Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9442477rdf:typepubmed:Citationlld:pubmed
pubmed-article:9442477lifeskim:mentionsumls-concept:C0026549lld:lifeskim
pubmed-article:9442477lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9442477lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9442477lifeskim:mentionsumls-concept:C0681797lld:lifeskim
pubmed-article:9442477lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9442477lifeskim:mentionsumls-concept:C0234402lld:lifeskim
pubmed-article:9442477lifeskim:mentionsumls-concept:C0870186lld:lifeskim
pubmed-article:9442477lifeskim:mentionsumls-concept:C0043966lld:lifeskim
pubmed-article:9442477lifeskim:mentionsumls-concept:C0147448lld:lifeskim
pubmed-article:9442477pubmed:issue8lld:pubmed
pubmed-article:9442477pubmed:dateCreated1998-3-10lld:pubmed
pubmed-article:9442477pubmed:abstractTextThe present study was designed to investigate the effects of the mu-opioid morphine, trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)- cyclohexyl]-benzene acetamide, methane sulfonate hydrate (U-50488H), a kappa-selective opioid receptor agonist, and 1,3-di-(2-tolyl)guanidine (DTG), sigma-receptor agonist, on the discriminative stimulus properties of cocaine in the rat trained to discriminate 10 mg/kg of cocaine from its vehicle in a shock avoidance paradigm. Morphine (1-5.6 mg/kg), U-50488H (1-10 mg/kg) or 1,3-di-(2-tolyl) guanidine (1 and 10 mg/kg) alone did not produce any stimulus effects in common with cocaine. In contrast, morphine (5.6 mg/kg) and DTG (10 mg/kg), unlike U-50488H (10 mg/kg), significantly shifted the stimulus-generalization curve for cocaine to the left. These results suggest that agonists for mu-opioid- and sigma-receptors augment the discriminative stimulus properties of cocaine.lld:pubmed
pubmed-article:9442477pubmed:languageenglld:pubmed
pubmed-article:9442477pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:citationSubsetIMlld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9442477pubmed:statusMEDLINElld:pubmed
pubmed-article:9442477pubmed:monthOctlld:pubmed
pubmed-article:9442477pubmed:issn0379-0355lld:pubmed
pubmed-article:9442477pubmed:authorpubmed-author:KameyamaTTlld:pubmed
pubmed-article:9442477pubmed:authorpubmed-author:MoroCClld:pubmed
pubmed-article:9442477pubmed:authorpubmed-author:UkaiMMlld:pubmed
pubmed-article:9442477pubmed:issnTypePrintlld:pubmed
pubmed-article:9442477pubmed:volume19lld:pubmed
pubmed-article:9442477pubmed:ownerNLMlld:pubmed
pubmed-article:9442477pubmed:authorsCompleteYlld:pubmed
pubmed-article:9442477pubmed:pagination541-6lld:pubmed
pubmed-article:9442477pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:meshHeadingpubmed-meshheading:9442477-...lld:pubmed
pubmed-article:9442477pubmed:year1997lld:pubmed
pubmed-article:9442477pubmed:articleTitleModulatory effects of morphine, U-50488H and 1,3-di-(2-tolyl)guanidine on cocaine-like discriminative stimulus in the rat using two-choice discrete-trial avoidance paradigm.lld:pubmed
pubmed-article:9442477pubmed:affiliationDepartment of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan.lld:pubmed
pubmed-article:9442477pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9442477pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9442477lld:pubmed